1 | ANTI-interleukin-23 immunoglobulin G2 (IGG2) human monoclonal antibody | - | - | - | - | 2件: 96 96, 97 💬
|
2 | Denosumab - - immunoglobulin G2 human monoclonal antibody TO rank ligand | 1件: Denosumab Denosumab | 1件: Denosumab
Denosumab
💬
| 1件: TNFSF11 TNFSF11 💬
| 8件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | 1件: 274 274 💬
|
3 | Denosumab - immunoglobulin G2 human monoclonal antibody TO rank ligand | 1件: Denosumab Denosumab | 1件: Denosumab
Denosumab
💬
| 1件: TNFSF11 TNFSF11 💬
| 8件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | 1件: 274 274 💬
|
4 | Human immunoglobulin G | 1件: Human immunoglobulin G Human immunoglobulin G (Human immunoglobulin G) | 1件: Globulin, immune
Globulin, immune
💬
| - | - | 3件: 14 14, 50, 63 💬
|
5 | Humanized immunoglobulin gamma 1 (IGG1) kappa monoclonal antibody | - | - | - | - | 1件: 46 46 💬
|
6 | Immunoglobulin G | - | - | - | - | 9件: 2 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
|
7 | Immunoglobulin G cleaving cystein protease derived from E. coli | - | - | - | - | 2件: 43 43, 44 💬
|
8 | Immunoglobulin G1, anti (protein nogo A) (human MUS musculus monoclonal heavy | - | - | - | - | 1件: 2 2 💬
|
9 | Immunoglobulin G1, anti (protein nogo A) (human MUS musculus monoclonal heavy chain), disulfide with human MUS musculus monoclonal light chain, dimer | - | - | - | - | 1件: 2 2 💬
|
10 | Immunoglobulin G1, ANTI-(human type I interferon receptor) (human monoclonal MEDI-546 heavy chain), disulfide with human monoclonal MEDI-546-chain, dimer | - | - | - | - | 1件: 49 49 💬
|
11 | Normal human immunoglobulin G | - | - | - | - | 1件: 65 65 💬
|